The Council of the European Union has adopted proposals that would see the whole hemp plant, including inflorescences and leaves, recognised as an ordinary agricultural product.
James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation and more controlled delivery could help realise it.
Britain is on course to become the first country in the world to formally authorise cannabidiol (CBD) as a novel food, as the Food Standards Agency (FSA) recommends three applications for ministerial approval in a move that could bring an estimated 3,000 products into legal compliance.
Despite the Council of State knocking back its initial attempt to derail the French authorities’ latest crackdown on CBD, the head of the trade groups fighting the ban remain upbeat on its chances of success.
The director of UK CBD brand Virtutum Limited, which traded as CBD Asylum in Hull, has been given a suspended prison sentence for fraud and money laundering.
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
French trade groups are seeking to overturn the ban on the sale of CBD food supplements in an attempted re-run of the successful 2022 removal of the ban on the sale of flowers.
Last week (April 27), the deadline for Greek industry stakeholders to have their say on a controversial new hemp ban expired.
The long and arduous journey to regulate cannabidiol (CBD) in Europe, which began in 2018 with the European Union’s classification of CBD as a ‘novel food’, is now playing out in the courtrooms of the United States.
